Published in
American Society of Nephrology, Clinical Journal of the American Society of Nephrology, 9(4), p. 1409-1416, 2009
DOI: 10.2215/cjn.01520209
Links
- ORCID
- ORCID
- American Society of Nephrology
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Risk Factors for Cyclosporin A Nephrotoxicity in Children with Steroid-Dependant Nephrotic Syndrome
Journal article published in 2009 by
Severin-Wafo Kengne,
Laura Massella,
Francesca-Camassei Diomedi 
,
Alessandra Gianviti,
Marina Vivarelli ,
Marcella Greco,
Gilda Stringini Rita,
Gilda Rita Stringini,
Francesco Emma
,
Alessandra Gianviti,
Marina Vivarelli ,
Marcella Greco,
Gilda Stringini Rita,
Gilda Rita Stringini,
Francesco Emma
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Background and objectives: Cyclosporin A (CsA) is a well-established treatment for steroid-dependent nephrotic syndrome (SDNS) that may, however, cause chronic ischemic renal lesions. The objective of the study was to assess the prevalence of CsA nephrotoxicity (CsAN) in protocol biopsies of children with SDNS.